368 related articles for article (PubMed ID: 12494605)
1. [5-alpha reductase inhibitors or alpha blockers? The combination brakes best prostatic hyperplasia].
MMW Fortschr Med; 2002 Oct; 144(44):56. PubMed ID: 12494605
[No Abstract] [Full Text] [Related]
2. [5-alpha reductase inhibitors plus alpha blockers. A combination therapy keeps a common disease checked].
MMW Fortschr Med; 2003 Jul; 145(27-28):58-9. PubMed ID: 14587193
[No Abstract] [Full Text] [Related]
3. [Therapy of benign prostatic hyperplasia with finasteride and doxazosin -- long-term studies support the combination].
Hausmann R; Thalmann G; Reich O; Steif CG
Aktuelle Urol; 2004 Sep; 35(5):339-42. PubMed ID: 15383991
[No Abstract] [Full Text] [Related]
4. Finasteride in benign prostatic hyperplasia.
Verhamme KM; Bosch RJ; Sturkenboom MC
N Engl J Med; 2004 Mar; 350(13):1359-61; author reply 1359-61. PubMed ID: 15049034
[No Abstract] [Full Text] [Related]
5. [Benign prostatic hyperplasia: medical therapy].
Schlenker B; Gratzke C; Weidlich P; Seitz M; Reich O; Stief CG
MMW Fortschr Med; 2007 Aug; 149(33-34):29-31; quiz 32. PubMed ID: 17912863
[TBL] [Abstract][Full Text] [Related]
6. The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia.
McConnell JD; Roehrborn CG; Bautista OM; Andriole GL; Dixon CM; Kusek JW; Lepor H; McVary KT; Nyberg LM; Clarke HS; Crawford ED; Diokno A; Foley JP; Foster HE; Jacobs SC; Kaplan SA; Kreder KJ; Lieber MM; Lucia MS; Miller GJ; Menon M; Milam DF; Ramsdell JW; Schenkman NS; Slawin KM; Smith JA;
N Engl J Med; 2003 Dec; 349(25):2387-98. PubMed ID: 14681504
[TBL] [Abstract][Full Text] [Related]
7. Second opinion. I have benign prostatic hyperplasia. The drug my doctor prescribed has helped somewhat, but I'm still making a lot of trips to the bathroom at night. Short of surgery, are there any new approaches to managing this condition that might be more helpful?
Mayo Clin Health Lett; 2002 Dec; 20(12):8. PubMed ID: 12526112
[No Abstract] [Full Text] [Related]
8. [The tested combination is recommended. Are 5-alpha reductase inhibitors interchangeable?].
MMW Fortschr Med; 2003 Jul; 145(27-28):59. PubMed ID: 14587194
[No Abstract] [Full Text] [Related]
9. Two-drug therapy is best for symptomatic prostate enlargement: could a combination of doxazosin and finasteride change clinical practice?
Fitzpatrick JM; Kirby RS
BJU Int; 2004 May; 93(7):914-5. PubMed ID: 15142134
[No Abstract] [Full Text] [Related]
10. [Using doxasosine and finasteride combination in the treatment of prostate adenoma].
Bogdanov AB; Luk'ianov IV; Veliev EI
Urologiia; 2006; (5):59-63. PubMed ID: 17444154
[TBL] [Abstract][Full Text] [Related]
11. Finasteride and doxazosin alone or in combination for the treatment of benign prostatic hyperplasia.
Bhardwa J; Goldstraw M; Tzortzis S; Kirby R
Expert Opin Pharmacother; 2007 Jun; 8(9):1337-44. PubMed ID: 17563267
[TBL] [Abstract][Full Text] [Related]
12. Benign prostatic hyperplasia.
Doherty AP
Hosp Med; 2003 Feb; 64(2):114. PubMed ID: 12619342
[No Abstract] [Full Text] [Related]
13. Medical management of benign prostatic hyperplasia--are two drugs better than one?
Vaughan ED
N Engl J Med; 2003 Dec; 349(25):2449-51. PubMed ID: 14681512
[No Abstract] [Full Text] [Related]
14. Re: an economic evaluation of doxazosin, finasteride and combination therapy in the treatment of benign prostatic hyperplasia.
DiSantostefano RL; Biddle AK; Lavelle JP
Can J Urol; 2005 Feb; 12(1):2508-9; author reply 2509-10. PubMed ID: 15777487
[No Abstract] [Full Text] [Related]
15. [A trial of the use of finasteride and terazosin in patients with benign prostatic hyperplasia].
Pushkar' DIu; Kosko DV; Loran OB; Kan IaD; Sapozhnikov IM; Tevlin KP
Urol Nefrol (Mosk); 1995; (4):32-5. PubMed ID: 7571199
[TBL] [Abstract][Full Text] [Related]
16. [Benign prostatic syndrome. 3-step plan for the treatment].
MMW Fortschr Med; 2003 Sep; 145(39):52. PubMed ID: 14649077
[No Abstract] [Full Text] [Related]
17. Benign prostatic hyperplasia (BPH).
Harv Mens Health Watch; 2006 Aug; 11(1):3. PubMed ID: 17111474
[No Abstract] [Full Text] [Related]
18. [Drug treatment of benign prostatic hyperplasia].
Schmid HP
Praxis (Bern 1994); 1995 Sep; 84(39):1061-2. PubMed ID: 7481307
[No Abstract] [Full Text] [Related]
19. The impact of 5-alpha-reductase inhibitors on the number of prostatectomies for benign prostatic hyperplasia.
Agha AH; Roy JB; Culkin DJ; Lyon K
Adv Ther; 1995; 12(6):361-6. PubMed ID: 10163332
[TBL] [Abstract][Full Text] [Related]
20. Should patients with benign prostatic hypertrophy stop taking doxazosin in the light of the ALLHAT study?
Cheng TO
Int J Cardiol; 2006 Feb; 107(2):275-6. PubMed ID: 16412808
[No Abstract] [Full Text] [Related]
[Next] [New Search]
